Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 19/20 | 0.43 |
| ▸ | RARB | P10826 | 12/20 | 0.43 |
| ▸ | RARG | P13631 | 11/20 | 0.43 |
| ▸ | RXRB | P28702 | 8/20 | 0.43 |
| ▸ | RARA | P10276 | 7/20 | 0.43 |
| ▸ | RXRG | P48443 | 7/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.40 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | DRD1 | P21728 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30368657 | 1.00 | RXRA (0.43) | RXRARARBRARGRXRBRARA | |
| SCHEMBL12418596 | 0.83 | RXRA (0.50) | RXRARARBRARGRXRBRARA | |
| SCHEMBL11122818 | 0.81 | RARB (0.41) | RXRARARBRARGRXRBRARA | |
| SCHEMBL30232111 | 0.81 | RARG (0.41) | RXRARARBRARGRXRBRARA | |
| SCHEMBL8056473 | 0.81 | RARG (0.41) | RXRARARBRARGRXRBRARA | |
| SCHEMBL8807547 | 0.77 | RXRA (0.44) | RXRARARBRARGRXRBRARA | |
| SCHEMBL3298635 | 0.77 | RXRA (0.61) | RXRARARBRARGRXRBRARA | |
| SCHEMBL726366 | 0.77 | RXRA (0.59) | RXRARARBRARGRXRBRARA | |
| SCHEMBL29260311 | 0.75 | POLA1 (0.34) | — | |
| SCHEMBL9859988 | 0.75 | RXRA (0.60) | RXRARARBRARGRXRBRARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10336966-B2 | Fragrance compositions and uses thereof | THE PROCTER & GAMBLE COMPANY (US) | 2019-07-02 | — | — | US | claimed |
| US-6147049-A | FRAGRANCE COMPOSITION | GIVAUDAN ROURE (INTERNATIONAL) SA (CH) | 2000-11-14 | — | — | US | claimed |
| EP-1010686-A1 | New Tetrahydronaphthalenes | Givaudan Roure (International) S.A. (CH) | 2000-06-21 | — | — | EP | claimed |
| EP-1010685-A1 | New tetrahydronaphthalenes | Givaudan Roure (International) S.A. (CH) | 2000-06-21 | — | — | EP | claimed |
| US-12527733-B2 | Fragrance compositions | ELC MANAGEMENT LLC (US) | 2026-01-20 | — | — | US | disclosed |
| EP-3103523-B1 | ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION | PROCTER & GAMBLE (US) | 2025-10-29 | — | — | EP | disclosed |
| EP-4384137-A1 | FRAGRANCE COMPOSITIONS | ELC Management LLC (US) | 2024-06-19 | — | — | EP | disclosed |
| US-20230048533-A1 | FRAGRANCE COMPOSITIONS | ELC MANAGEMENT LLC | 2023-02-16 | — | — | US | disclosed |
| WO-2023018673-A1 | FRAGRANCE COMPOSITIONS | ELC MANAGEMENT LLC (US) | 2023-02-16 | — | — | WO | disclosed |
| US-20210393506-A1 | FRAGRANCE BLENDS AND METHODS FOR PREPARATION THEREOF | JPMORGAN CHASE BANK, N.A. | 2021-12-23 | — | — | US | disclosed |
| EP-3103431-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | The Procter and Gamble Company (US) | 2016-12-14 | — | — | EP | disclosed |
| EP-3103523-A1 | ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION | The Procter and Gamble Company (US) | 2016-12-14 | — | — | EP | disclosed |
| US-6147049-A | FRAGRANCE COMPOSITION | GIVAUDAN ROURE (INTERNATIONAL) SA (CH) | 2000-11-14 | — | — | US | disclosed |
| JP-2000219651-A | NEW TETRAHYDRONAPHTHALENE | GIVAUDAN ROURE INTERNATL SA | 2000-08-08 | — | — | JP | disclosed |
| EP-1010686-A1 | New Tetrahydronaphthalenes | Givaudan Roure (International) S.A. (CH) | 2000-06-21 | — | — | EP | disclosed |
| EP-1010685-A1 | New tetrahydronaphthalenes | Givaudan Roure (International) S.A. (CH) | 2000-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10336966-B2 | Fragrance compositions and uses thereof | CUTA, DPM1, PLIN5 | RXRA 1429/4885RARB 2984/4885RARG 1890/4885 |
| US-12527733-B2 | Fragrance compositions | CUTA, IL36G, TAS2R40 | RXRA 2643/4885RARB 1335/4885RARG 465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.